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ABSTRACT
Objectives: To evaluate magnetic resonance elastography as a tool for characterizing uterine leimyomas. 
Material and methods: At total of 12 women with symptomatic leiomyomas diagnosed in physical and ultrasound ex-
aminations were enrolled in this pilot study. Before surgery, all patients underwent magnetic resonance elastography of 
the uterus using a 1.5 T MR whole-body scanner (Optima, GE Healthcare, Milwaukee, WI, USA). Surgical specimens were 
forwarded for histological examination. The findings were allocated into 3 categories depending on the percentage content 
of connective tissue: below 15%, from 15 to 30% and more than 30%. The median stiffness of leiomyomas for each of the 
group was calculated. The U-Mann Whitney test was used for statistical analysis. 
Results: The stiffness of the leiomyomas ranged between 3.7–6.9 kPa (median value 4.9 kPa). The concentration of extracel-
lular components in the leiomyomas did not exceed 40%. An increasing trend of the stiffness with the growing percentage 
of extracellular component was observed. Stiffness of the leiomyomas obtained by MRE varies depending on microscopic 
composition. 
Conclusions: The value of stiffness shows a trend of increasing with the percentage of extracellular component of the 
leiomyoma. Further studies are required to assess the usefulness of MRE in diagnostics of uterine leiomyomas.
Key words: leiomyoma; magnetic resonance elastography; histologic composition 
Ginekologia Polska 2020; 91, 7: 373–378
INTRODUCTION
Uterine leiomyomas (fibroids) are the most common 
benign gynaecological tumours, which affect up to 70% of 
women of a reproductive age [1–3]. They develop as a result 
of the transformation of myometrial smooth muscle, fibro-
blasts and the formation of a dysfunctional extracellular 
matrix [4, 5]. The majority of fibroids remain asymptomatic, 
20–40% of women with leiomyomas report significant clini-
cal symptoms (e.g. abnormal uterine bleeding, dysmenor-
rhea, pelvic pain, infertility, and recurrent pregnancy loss) 
that require effective gynaecological intervention [2, 6, 7].
The management of uterine fibromas varies significantly 
depending on the patient’s age, symptoms, and reproduc-
tive plans. For women who wish to preserve their fertility 
and avoid surgery, there are numerous medical therapy 
options available [8]. For symptomatic women after medi-
cal treatment failures, surgical procedures are proposed [9]. 
Strategies for surgical treatment depend on the patient 
and fibroid characteristics and include myomectomy (in 
women who want to preserve their uterus or desire future 
pregnancy) or hysterectomy (for women after a completed 
childbearing) [9]. Currently, both procedures are mostly 
performed via laparoscopy with the usage of a power mor-
cellator. Laparoscopic power morcellation is related with 
a risk of spreading undiagnosed neoplastic tissue within 
the abdominal cavity, which may significantly worsen the 
patient’s prognosis [10–12]. The true prevalence of uterine 
sarcomas in presumed fibroids is not exactly known and 
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vary from 0.09% to 0,8% depending on the study [13–17]. 
Also, the medical management of presumed symptomatic 
leiomyoma, which is found to be sarcoma, may have a nega-
tive impact on the outcome due to a delay in appropriate 
therapy. Despite the fact that some patients’ characteristics 
and abnormal features of uterine tumors on a US or MRI may 
be suggestive for the presence of leiomyosarcoma, a reli-
able differential diagnosis is still very difficult [13, 18–20]. 
Hence, there is an urgent need for finding a new tool that 
could improve the characterization of uterine masses. In 
this context, interesting possibilities are offered in recently 
implemented magnetic resonance elastography (MRE). Ma-
lignant transformation often markedly alters the mechanical 
properties of soft tissue [21, 22], which could be potentially 
used in the pre-treatment differentiating leiomyosarcoma 
from the common leiomyoma. On the other hand, elas-
tographic patterns of the leiomyoma, reflecting a relative 
concentration of cellular and extracellular components, 
may be helpful in predicting a response to non- excisional 
therapies such as uterine artery embolization and magnetic 
resonance–guided focused ultrasound [23]. Both circum-
stances require knowledge of the typical elastographic 
features of leiomyomas.
Objectives
Until now, only two studies have been published on the 
feasibility of MRE for uterine leiomyomas, without regard to 
their microscopic composition [23, 24]. The aim of this study 
was to evaluate the correlation between the elasticity of 
leiomyomas obtained by MRE and their relative concentra-
tion of cellular and extracellular components.
MATERIAL AND METHODS
Patient population
This pilot study included 12 patients with symptomatic 
leiomyomas, who underwent surgical treatment at the Clini-
cal Department of Obstetrics and Gynaecology of Provincial 
Clinical Hospital No 2, Rzeszow , Poland between September 
2016 and February 2017.
Preoperative diagnosis was based on vaginal speculum 
examination, bimanual examination and the transvaginal 
ultrasonography of the uterus. Before surgery, all patients 
underwent laboratory tests, electrocardiography, anesthe-
siology consultation and magnetic resonance elastography 
of the uterus. Written consent was obtained from each of 
the patients before the study commenced. The research 
protocol was approved by the Bioethics Committee of the 
University of Rzeszow, Poland (Reg. No. 19/04/2016).
Magnetic Resonance Elastography 
A 1.5 T MR whole-body scanner (Optima, GE Healthcare, 
Milwaukee, WI, USA) was used to perform the MRE scans. The 
MRE system, includes special acquisition and processing 
software, as well as hardware consisting of an active and 
passive driver.  The passive driver is a small plastic drum-like 
device that is placed against the body to transmit mechani-
cal vibrations into tissue.  In this study, the passive driver was 
placed over the uterus in the lower abdomen. The passive 
driver is connected via flexible tubing to the active driver 
unit which is located outside the MRI room.  The active 
driver unit generates pressure pulses (at 60 Hz frequency 
in this study) that are conducted to the passive driver via 
the flexible tubing.
MRE acquisition was performed using a 16-channel ab-
dominal phase array coil. Shear wave imaging was conducted 
using a modified 2D gradient–recalled echo-based pulse se-
quence with the following parameters: matrix size: 256 × 256, 
slice thickness: 10 mm; TR: 33 ms; TE: 20 ms; flip angle: 
30 deg. The resulting wave images were then automatically 
processed by the scanner using a manufacturer-provided 2D 
direct inversion algorithm to generate quantitative images 
depicting tissue stiffness (elastograms) [25–27].
Region of interest (ROI) were drawn manually on the 
largest leiomyoma, avoiding non-fibroid tissue, using corre-
sponding T2 images as a guide. From the ROI, mean stiffness 
(kPa) and standard deviation, were reported.
Microscopic evaluation
Surgical specimens were forwarded for histological exam-
ination. To visualise the collagenous connective tissue fibers 
in tissue sections and differentiate them from smooth muscle 
fibers, Trichrome Stain (Connective Tissue Stain) was applied. 
In this process staining muscle fibers were dyed red, collagen 
fibers were stained blue and nuclei stained black/blue (Fig. 1). 
Due to lack of similar publications and other scientific data, 
the findings were arbitrarily allocated into 3 categories de-
pending on the percentage content of connective tissue 
(below 15%, from 15 to 30%, more than 30%).
Statistical analysis
Statistical analysis was performed using Python librar-
ies. The U-Mann Whitney tests were applied. A p value of 
lower than 0.05 was considered statistically significant.
RESULTS
A greater number of patients were premenopausal 
than not. Only one patient was postmenopausal. Their age 
ranged between 26–61 years (median value 40.5 years). The 
median body mass index (BMI) was 22.45 kg/m2. The parity 
status and type of surgery are presented in Table 1.
In all  patients, the preoperative diagnosis leiomyoma 
was confirmed histologically. The diameter of the largest 
leiomyoma ranged between 40–109 mm (median diameter 
68.5 mm). The median value of leiomyoma stiffness obtained 
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in our series was 4.9 kPa (range, 3.7–6.9) The concentration 
of extracellular components in the leiomyomas and their 
stiffness in specific patients are presented in Table 2. 
The biggest subgroup was made up of leiomyomas 
with contents of fibrous tissue up to 15 percent. The me-
dian stiffness in this series was 4.46 kPa. Three patients had 
leiomyomas with a concentration of extracellular compo-
nents between 15 and 30% and median stiffness of 5.78 kPa, 
respectively. More than 30% content of fibrous tissue was 
found in 2 patients. The median stiffness of those leiomyo-
mas was 6.15 kPa. Example ROI’s drawn on elastograms for 
three patients are shown in Figure 2.
Figure 3 depicts a box plot with the mean stiffness 
measurements among groups with different extracellular 
component. Despite the low number of samples, the in-
creasing trend of the stiffness with the growing percentage 
of extracellular component is clearly observable.  The p value 
for the stiffness difference between lesions with extracellular 
component of < 15% and > 30% was p = 0.05. Other results 
were not statistically significant.
DISCUSSION
Magnetic resonance elastography is a versatile 
MRI-based technique, using propagating shear waves to 
Table 1. Clinical characteristics of the study group
Patient Age Gravidity/Parity Hormonal status BMI Type of surgery
1 49 2/2 premenopausal 20.42 LASH/BS
2 33 0 premenopausal 21.48 laparotomy/myomectomy
3 32 0 premenopausal 24.77 laparotomy/myomectomy
4 28 1/1 premenopausal 19.16 laparoscopy/myomectomy
5 38 3/2 premenopausal 23.42 LASH/BS
6 31 2/2 premenopausal 26.17 LASH/BS
7 43 3/1 premenopausal 20.76 LASH/BS
8 48 2/2 premenopausal 21.09 TLH/BS
9 26 0 premenopausal 27.02 laparotomy/myomectomy
10 46 0 premenopausal 21.05 laparotomy/myomectomy
11 49 2/2 premenopausal 25.10 TLH/BS
12 61 3/1 postmenopausal 27.24 TAH/BSO
LASH — laparoscopic supracervical hysterectomy; TLH — total laparoscopic hysterectomy; TAH — total abdominal hysterectomy; BS — bilateral salpingectomy;  
BSO — bilateral salpingooophorectom
Figure 1. Microscopic pictures of leiomyomas with different 
histologic composition: fibrous tissue content up to 15% (A), between 
15% and 30% (B), and above 30% (C) in trichrome stain
Table 2. Pathology findings and magnetic resonance elastography 
data of the study group
Patient
Diameter 
of the 
leiomyoma 
[mm]
Extracellular 
component 
[%]
Stiffness 
of the 
leiomyoma
SD of 
leiomyomas’ 
stiffness
1 57 < 15 6.18 0.68
2 41 < 15 3.7 1.2
3 109 > 30 6.9 2.8
4 40 < 15 4.5 1.5
5 56 < 15 4.2 1.02
6 62 < 15 4.0 1.2
7 70 < 15 4.9 1.3
8 75 < 15 4.97 1.08
9 67 15–30 4.68 1.06
10 93 > 30 5.39 0.90
11 82 15–30 5.8 2.2
12 80 15–30 5.9 1.6
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assess the mechanical properties of tissue [28]. The most 
established and documented clinical application of MRE 
is the evaluation of chronic liver disease [29–33]. In recent 
years, MRE has also been evaluated in characterization of 
focal liver lesions [22, 34], and for assessing the spleen, 
pancreas, kidneys and prostate [35–39]. Experiences with 
MRE in the field of gynaecology are quite limited. There are 
only a few publications dealing with the stiffness of a normal 
uterus [40] and leiomyomas [23, 24]. None of the research 
groups investigated the stiffness of leiomyomas in correla-
tion with their histologic composition. In this context, our 
research provides data to fill this gap.
The present study confirms the findings of Stewart et 
al. [23], that magnetic resonance elastography is a feasible 
technique for the assessment of mechanical properties of 
uterine leiomyomas. The median value of leiomyoma stiff-
ness obtained in our series (4.9 kPa) was comparable to that 
of above cited study.
The stiffness of the leiomyoma is markedly higher than the 
stiffness of both the normal corpus and cervix uteri, which 
were evaluated by Jiang et al. using 3D MRE technique [40]. 
Compared to other pathologic lesions, the elasticity of leio-
myomas exceeds those of benign liver tumors (mean 2.7 kPa, 
range 1.6–3.2 kPa), but it is similar to the elasticity of fibrotic 
liver disease (mean 5.9 kPa, range 3.1–12.2 kPa) [22].
The content of the extracellular component in leiomyo-
mas from our series did not exceed 40%. The concentration 
of collagen fibres correlated with the value of stiffness of 
the leiomyoma (Fig. 3). Leiomyoma stiffness, as an increas-
ing trend, is observable with the increased extracellular 
component; however, statistical analysis only approached 
demonstrating a significant difference between the groups 
with the highest and lowest collagen concentration. The 
relatively large scatter of stiffness values in the group of 
lowest extracellular component is probably due to the in-
homogeneity of leiomyomas.  
To the best of our knowledge, this is the first study in-
vestigating the correlation between the elasticity of leio-
myomas obtained by MRE and their relative concentration 
of cellular and extracellular components. The presented 
observations can be potentially helpful in preoperative dif-
ferentiating common leiomyomas from their malign coun-
terparts. Because uterine sarcomas tend to be more cellular, 
they may be able to be distinguished from the leiomyomas 
based on the altered mechanical properties. This expecta-
tion is also related to the need for preoperative distinguish-
ing between common leiomyoma and  cellular leiomyoma, 
as they may have premalignant potential [41, 42]. Our series 
included neither leiomyosarcomas, nor cellular leiomyoma, 
so this hypothesis is purely theoretical. However, it seems to 
be justified based on similar observations regarding breast 
and liver tumors [21, 22, 34].
The limitation of the presented paper is the small size 
of the study group, and its one-institutional character. Mul-
ti-centre research with a larger patient series will be required 
to gain appropriate statistical power to objectively assess 
the usefulness of MRE in evaluating the microscopic compo-
sition of leiomyomas. Besides, in our study two-dimensional 
MRE have been used, which is limited in estimating the true 
mechanical property of tissue, especially in small lesions. It 
was the reason for our patient selection and qualifying only 
those with middle-size and larger leiomyoma. In the follow-
Figure 2. T2w MR images (column 1) and comparison of elastograms 
(column 2) for patient 6 (row A), 9 (row B) and 3 (row C). The  
mean stiffness was 3.95 kPa, 4.68 kPa and 6.9 kPa for the above 
mentioned patients, respectively
Figure 3. Box plot depicting variance in shear stiffness measurements 
for all groups of patients
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ing investigations a 3D-MRE should be used to overcome 
this limitation. 
CONCLUSIONS
In conclusion, this study demonstrates that stiffness 
of the leiomyomas obtained by MRE varies depending on 
their histologic composition. The value of stiffness shows 
a trend of increasing with growing percentage of extracel-
lular component of the leiomyoma. Further investigations 
with a larger patient group and 3D-MRE are needed to as-
sess the usefulness of MRE in evaluating leiomyomas and 
defining its possible clinical application. 
Acknowledgments
The study was performed within the project “Centre for Inno-
vative Research in Medical and Natural Sciences” realized by 
the University of Rzeszów, co- financed within the Regional 
Operational Program for the Podkarpackie Province for the 
years 2007–2013 (contract number UDA-RPPK.01.03.00-18- 
004/12-00). 
REFERENCES
1. Lumsden MA. Modern management of fibroids. Obstetrics, Gynae-
cology & Reproductive Medicine. 2013; 23(3): 65–70, doi: 10.1016/j.
ogrm.2013.02.001.
2. Marsh EE, Ekpo GE, Cardozo ER, et al. Racial differences in fibroid 
prevalence and ultrasound findings in asymptomatic young women 
(18-30  years old): a pilot study. Fertil Steril. 2013; 99(7): 1951–1957, 
doi: 10.1016/j.fertnstert.2013.02.017, indexed in Pubmed: 23498888.
3. Segars JH, Parrott EC, Nagel JD, et al. Proceedings from the Third Na-
tional Institutes of Health International Congress on Advances in Uterine 
Leiomyoma Research: comprehensive review, conference summary and 
future recommendations. Hum Reprod Update. 2014; 20(3): 309–333, 
doi: 10.1093/humupd/dmt058, indexed in Pubmed: 24401287.
4. Chegini N. Proinflammatory and profibrotic mediators: principal effec-
tors of leiomyoma development as a fibrotic disorder. Semin Reprod 
Med. 2010; 28(3): 180–203, doi: 10.1055/s-0030-1251476, indexed in 
Pubmed: 20414842.
5. Ryan GL, Syrop CH, Van Voorhis BJ. Role, epidemiology, and natural 
history of benign uterine mass lesions. Clin Obstet Gynecol. 2005; 
48(2): 312–324, doi: 10.1097/01.grf.0000159538.27221.8c, indexed in 
Pubmed: 15805789.
6. Downes E, Sikirica V, Gilabert-Estelles J, et al. The burden of uterine 
fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol. 
2010; 152(1): 96–102, doi: 10.1016/j.ejogrb.2010.05.012, indexed in 
Pubmed: 20598796.
7. Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated 
systematic review of the evidence. Fertil Steril. 2009; 91(4): 1215–1223, 
doi: 10.1016/j.fertnstert.2008.01.051, indexed in Pubmed: 18339376.
8. Kashani BN, Centini G, Morelli SS, et al. Role of Medical Management 
for Uterine Leiomyomas. Best Pract Res Clin Obstet Gynaecol. 2016; 
34: 85–103, doi: 10.1016/j.bpobgyn.2015.11.016, indexed in Pubmed: 
26796059.
9. Thubert T, Foulot H, Vinchant M, et al. Surgical treatment: Myomec-
tomy and hysterectomy; Endoscopy: A major advancement. Best Pract 
Res Clin Obstet Gynaecol. 2016; 34: 104–121, doi: 10.1016/j.bpob-
gyn.2015.11.021, indexed in Pubmed: 27400649.
10. Perri T, Korach J, Sadetzki S, et al. Uterine leiomyosarcoma: does the 
primary surgical procedure matter? Int J Gynecol Cancer. 2009; 19(2): 
257–260, doi: 10.1111/IGC.0b013e31819a1f8f, indexed in Pubmed: 
19396005.
11. Park JY, Park SK, Kim DY, et al. The impact of tumor morcellation dur-
ing surgery on the prognosis of patients with apparently early uterine 
leiomyosarcoma. Gynecol Oncol. 2011; 122(2): 255–259, doi: 10.1016/j.
ygyno.2011.04.021, indexed in Pubmed: 21565389.
12. George S, Barysauskas C, Serrano C, et al. Retrospective cohort study 
evaluating the impact of intraperitoneal morcellation on outcomes of 
localized uterine leiomyosarcoma. Cancer. 2014; 120(20): 3154–3158, 
doi: 10.1002/cncr.28844, indexed in Pubmed: 24923260.
13. Leibsohn S, d’Ablaing G, Mishell D, et al. Leiomyosarcoma in a series of 
hysterectomies performed for presumed uterine leiomyomas. Ameri-
can Journal of Obstetrics and Gynecology. 1990; 162(4): 968–976, doi: 
10.1016/0002-9378(90)91298-q.
14. Uterine Leiomyoma. SpringerReference. , doi: 10.1007/springerrefer-
ence_177792.
15. Rowland M, Lesnock J, Edwards R, et al. Occult uterine cancer in patients 
undergoing laparoscopic hysterectomy with morcellation: Implications 
for surveillance for disease recurrence and outcomes. Gynecologic On-
cology. 2013; 130(1): e77, doi: 10.1016/j.ygyno.2013.04.243.
16. Ehdaivand S, Simon RA, Sung CJ, et al. Incidental gynecologic neoplasms 
in morcellated uterine specimens: a case series with follow-up. Hum 
Pathol. 2014; 45(11): 2311–2317, doi: 10.1016/j.humpath.2014.07.018, 
indexed in Pubmed: 25257577.
17. Seidman MA, Oduyebo T, Muto MG, et al. Peritoneal dissemination 
complicating morcellation of uterine mesenchymal neoplasms. PLoS 
One. 2012; 7(11): e50058, doi: 10.1371/journal.pone.0050058, indexed 
in Pubmed: 23189178.
18. Goto A, Takeuchi S, Sugimura K, et al. Usefulness of Gd-DTPA contrast-en-
hanced dynamic MRI and serum determination of LDH and its isozymes 
in the differential diagnosis of leiomyosarcoma from degenerated 
leiomyoma of the uterus. Int J Gynecol Cancer. 2002; 12(4): 354–361, 
doi: 10.1046/j.1525-1438.2002.01086.x, indexed in Pubmed: 12144683.
19. Tanaka YO, Nishida M, Tsunoda H, et al. Smooth muscle tumors of 
uncertain malignant potential and leiomyosarcomas of the uterus: 
MR findings. J Magn Reson Imaging. 2004; 20(6): 998–1007, doi: 
10.1002/jmri.20207, indexed in Pubmed: 15558559.
20. Testa AC, Di Legge A, Bonatti M, et al. Imaging techniques for evaluation 
of uterine myomas. Best Pract Res Clin Obstet Gynaecol. 2016; 34: 37–53, 
doi: 10.1016/j.bpobgyn.2015.11.014, indexed in Pubmed: 26803557.
21. Krouskop TA, Wheeler TM, Kallel F, et al. Elastic moduli of breast and pros-
tate tissues under compression. Ultrason Imaging. 1998; 20(4): 260–274, 
doi: 10.1177/016173469802000403, indexed in Pubmed: 10197347.
22. Venkatesh SK, Yin M, Glockner JF, et al. MR elastography of liver tumors: 
preliminary results. AJR Am J Roentgenol. 2008; 190(6): 1534–1540, doi: 
10.2214/AJR.07.3123, indexed in Pubmed: 18492904.
23. Stewart EA, Taran FA, Chen J, et al. Magnetic resonance elastography of 
uterine leiomyomas: a feasibility study. Fertil Steril. 2011; 95(1): 281–284, 
doi: 10.1016/j.fertnstert.2010.06.004, indexed in Pubmed: 20633880.
24. Jondal DE, Wang J, Chen J, et al. Uterine fibroids: correlations between 
MRI appearance and stiffness via magnetic resonance elastography. 
Abdom Radiol (NY). 2018; 43(6): 1456–1463, doi: 10.1007/s00261-017-
1314-1, indexed in Pubmed: 28952003.
25. Manduca A, Oliphant TE, Dresner MA, et al. Magnetic resonance elas-
tography: non-invasive mapping of tissue elasticity. Med Image Anal. 
2001; 5(4): 237–254, doi: 10.1016/s1361-8415(00)00039-6, indexed in 
Pubmed: 11731304.
26. Oliphant TE, Manduca A, Ehman RL, et al. Complex-valued stiffness 
reconstruction for magnetic resonance elastography by algebraic 
inversion of the differential equation. Magn Reson Med. 2001; 45(2): 
299–310, doi: 10.1002/1522-2594(200102)45:2<299::aid-mrm1039>3.
0.co;2-o, indexed in Pubmed: 11180438.
27. Manduca A, Lake DS, Kruse SA, et al. Spatio-temporal directional filtering 
for improved inversion of MR elastography images. Med Image Anal. 
2003; 7(4): 465–473, doi: 10.1016/s1361-8415(03)00038-0, indexed in 
Pubmed: 14561551.
28. Venkatesh SK, Ehman RL. Magnetic resonance elastography of abdomen. 
Abdom Imaging. 2015; 40(4): 745–759, doi: 10.1007/s00261-014-0315-6, 
indexed in Pubmed: 25488346.
29. Ichikawa S, Motosugi U, Ichikawa T, et al. Magnetic resonance elastography 
for staging liver fibrosis in chronic hepatitis C. Magn Reson Med Sci. 2012; 
11(4): 291–297, doi: 10.2463/mrms.11.291, indexed in Pubmed: 23269016.
30. Hennedige TP, Wang G, Leung FP, et al. Magnetic resonance elastography 
for the detection and staging of liver fibrosis in chronic hepatitis B. Eur 
Radiol. 2014; 24(1): 70–78, doi: 10.1007/s00330-013-2978-8, indexed in 
Pubmed: 23928932.
31. Huwart L, Sempoux C, Vicaut E, et al. Liver fibrosis: noninvasive assess-
ment with MR elastography versus aspartate aminotransferase-to-plate-
let ratio index. Radiology. 2007; 245(2): 458–466, doi: 10.1148/ra-
diol.2452061673, indexed in Pubmed: 17940304.
378
Ginekologia Polska 2020, vol. 91, no. 7
www. journals.viamedica.pl/ginekologia_polska
32. Kim BoH, Lee JM, Lee YeJi, et al. MR elastography for noninvasive as-
sessment of hepatic fibrosis: experience from a tertiary center in Asia. 
J Magn Reson Imaging. 2011; 34(5): 1110–1116, doi: 10.1002/jmri.22723, 
indexed in Pubmed: 21932355.
33. Lee Yeji, Lee JM, Lee JE, et al. MR elastography for noninvasive assessment of 
hepatic fibrosis: reproducibility of the examination and reproducibility and 
repeatability of the liver stiffness value measurement. J Magn Reson Imaging. 
2014; 39(2): 326–331, doi: 10.1002/jmri.24147, indexed in Pubmed: 23589232.
34. Garteiser P, Doblas S, Daire JL, et al. MR elastography of liver tumours: value of 
viscoelastic properties for tumour characterisation. Eur Radiol. 2012; 22(10): 
2169–2177, doi: 10.1007/s00330-012-2474-6, indexed in Pubmed: 22572989.
35. Nedredal GI, Yin M, McKenzie T, et al. Portal hypertension correlates 
with splenic stiffness as measured with MR elastography. J Magn Re-
son Imaging. 2011; 34(1): 79–87, doi: 10.1002/jmri.22610, indexed in 
Pubmed: 21608066.
36. Shi Yu, Glaser KJ, Venkatesh SK, et al. Feasibility of using 3D MR elastog-
raphy to determine pancreatic stiffness in healthy volunteers. J Magn 
Reson Imaging. 2015; 41(2): 369–375, doi: 10.1002/jmri.24572, indexed 
in Pubmed: 24497052.
37. Rouvière O, Souchon R, Pagnoux G, et al. Magnetic resonance elas-
tography of the kidneys: feasibility and reproducibility in young 
healthy adults. J Magn Reson Imaging. 2011; 34(4): 880–886, doi: 
10.1002/jmri.22670, indexed in Pubmed: 21769970.
38. Arani A, Da Rosa M, Ramsay E, et al. Incorporating endorectal MR elas-
tography into multi-parametric MRI for prostate cancer imaging: Initial 
feasibility in volunteers. J Magn Reson Imaging. 2013; 38(5): 1251–1260, 
doi: 10.1002/jmri.24028, indexed in Pubmed: 23408516.
39. Sahebjavaher RS, Baghani A, Honarvar M, et al. Transperineal prostate 
MR elastography: initial in vivo results. Magn Reson Med. 2013; 69(2): 
411–420, doi: 10.1002/mrm.24268, indexed in Pubmed: 22505273.
40. Jiang X, Asbach P, Streitberger KJ, et al. In vivo high-resolution magnetic 
resonance elastography of the uterine corpus and cervix. Eur Radiol. 
2014; 24(12): 3025–3033, doi: 10.1007/s00330-014-3305-8, indexed in 
Pubmed: 25038856.
41. Giuntoli RL, Gostout BS, DiMarco CS, et al. Diagnostic criteria for uterine 
smooth muscle tumors: leiomyoma variants associated with malignant 
behavior. J Reprod Med. 2007; 52(11): 1001–1010, indexed in Pubmed: 
18161397.
42. Taran FA, Weaver AL, Gostout BS, et al. Understanding cellular 
leiomyomas: a case-control study. Am J Obstet Gynecol. 2010; 203(2): 
109.e1–109.e6, doi: 10.1016/j.ajog.2010.03.018, indexed in Pubmed: 
20451890.
